Tetrabenazine as a cause of neuroleptic malignant syndrome.
Ossemann
M
M
Sindic
C J
CJ
Laterre
C
C
D018726:Anti-Dyskinesia Agents / Q000009:adverse effects* / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D006801:Humans; D006816:Huntington Disease / Q000188:drug therapy*; D008134:Long-Term Care; D008297:Male; D008875:Middle Aged; D009459:Neuroleptic Malignant Syndrome / Q000209:etiology*; D013747:Tetrabenazine / Q000009:adverse effects* / Q000627:therapeutic use
D018726:Anti-Dyskinesia Agents; D013747:Tetrabenazine